Drug Trial Radar · NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Jun 30, 2022
Primary completion
Sep 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine
Conditions
- Schizophrenia
- Bipolar I Disorder
Interventions
OLZ/SAMDrug
OLZ/SAM refers to the fixed dose combination of olanzapine and samidorphan. The starting dose of olanzapine will be 2.5 mg/day or 5 mg/day at the discretion of the Investigator with a maximum daily dose of 20mg/day. The starting dose of samidorphan will be 5 or 10 mg.
OlanzapineDrug
The starting dose of olanzapine will be 2.5 mg/day or 5 mg/day at the discretion of the Investigator with a maximum daily dose of 20mg/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in body mass index (BMI) Zscore at week 12Time frame: 12 weeks
Locations
47 sites in 5 countries. Site status is shown where the registry gives one.
Alkermes Investigator Site
Dothan, Alabama · Recruiting
Alkermes Investigator Site
Little Rock, Arkansas · Recruiting
Alkermes Investigator Site
Encino, California · Withdrawn
Alkermes Investigator Site
Stanford, California · Recruiting
Alkermes Investigator Site
Upland, California · Withdrawn
Alkermes Investigator Site
Colorado Springs, Colorado · Withdrawn
Alkermes Investigator Site
Denver, Colorado · Active not recruiting
Alkermes Investigator Site
Hartford, Connecticut · Withdrawn
Alkermes Investigator Site
Washington D.C., District of Columbia · Recruiting
Alkermes Investigator Site
Miami, Florida · Withdrawn
Alkermes Investigator Site
Miami Lakes, Florida · Recruiting
Alkermes Investigator Site
Decatur, Georgia · Recruiting
Alkermes Investigator Site
Chicago, Illinois · Recruiting
Alkermes Investigator Site
Indianapolis, Indiana · Recruiting
Alkermes Investigator Site
Saint Charles, Missouri · Recruiting
Alkermes Investigator Site
Lincoln, Nebraska · Recruiting
Alkermes Investigator Site
Omaha, Nebraska · Withdrawn
Alkermes Investigator Site
Paramus, New Jersey · Withdrawn
Alkermes Investigator Site
New York, New York · Recruiting
Alkermes Investigational Site
Kinston, North Carolina · Withdrawn
Alkermes Investigator Site
Cincinnati, Ohio · Recruiting
Alkermes Investigator Site
West Chester, Ohio · Recruiting
Alkermes Investigator Site
DeSoto, Texas · Terminated
Alkermes Investigator Site
Fort Worth, Texas · Withdrawn
Alkermes Investigational Site
Richmond, Virginia · Recruiting
Alkermes Investigator Site
Everett, Washington · Recruiting
Alkermes Investigator Site
Buenos Aires, Argentina · Recruiting
Alkermes Investigator Site
Córdoba, Argentina · Recruiting
Alkermes Investigator Site
Mendoza, Argentina · Recruiting
Alkermes Investigator Site
La Plata, Buenos Aires, Argentina · Recruiting
Alkermes Investigator Site
La Plata, Buenos Aires, Argentina · Recruiting
Alkermes Investigator Site
Goiânia, Brazil · Recruiting
Alkermes Investigator Site
Rio de Janeiro, Brazil · Recruiting
Alkermes Investigator Site
São Paulo, Brazil · Recruiting
Alkermes Investigator Site
São Paulo, Brazil · Recruiting
Alkermes Investigator Site
Fortaleza, Ceará, Brazil · Recruiting
Alkermes Investigator Site
Curitiba, Paraná, Brazil · Recruiting
Alkermes Investigator Site
Barranquilla, Colombia · Recruiting
Alkermes Investigator Site
Bello, Colombia · Recruiting
Alkermes Investigator Site
Bogotá, Colombia · Active not recruiting
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.